SecBot SecBot

VSEE

VSEE HEALTH, INC.
OTC· Services-Health Services· Inc. DE· CIK 0001864531 Healthcare & Medical Devices
—
Market cap
$2.8M
Nano cap
Next earnings
Nov 12
in 17 days
Since first trade
+2.8%
from $1.80 · Sep 24
30 days
+8.8%
from $1.70
Range since listing
$1.55–2.28
−19% from high · low Sep 29
Avg volume 7D
9.2K
shares / day
Short interest
787.7K
≈1.4% of shares · −47.1%
Days to cover
1.0
at average volume
Insider net
$0
no open-market trades · 12 mo
New fund stakes
0
Q2 2026 13F · 0 exits
Filing reports
3
analyzed by SecBot
SecBot read BEARISH 1 report · 90 days
Balance 1 bearish · 0 bullish oldest → newest, height = score
Avg score ·High conf. 1/1 ·Next Earnings date, Nov 12, 2026
Strongest BEARISH VSee Health filed an S-1 registration statement to register up to 3,540,000 shares of common stock for…
All reports →

Price

Daily candles with volume. Pins mark insider trades, rating changes, 13F stakes, reports, catalysts and short-interest jumps.

Signal stack

Where each data set points today.

  • InsidersNO TRADES

    No open-market buys or sells in 12 months. Recent filings are awards, exercises and tax withholding.

  • InstitutionsMIXED

    Q2 2026: 1 added (0 new), 2 trimmed or exited.

  • Short sellersCOVERING

    Short interest −47.1% to 787.7K shares. 1.0 days to cover, ≈1.4% of shares.

Who's buying

13F· Q2 2026
0
new positions
0
exits
FundMoveSharesValue
VANGUARD FIDUCIARY TRUST CODOUBLED354,298$41.1K
GEODE CAPITAL MANAGEMENT, LLCTRIM207,081$23.9K
UBS Group AGTRIM18,022$2.1K
GEODE CAPITAL MANAGEMENT, LLCDOUBLED437,599$109.4K
UBS Group AGADD35,160$8.8K
OSAIC HOLDINGS, INC.ADD72,670$26.9K
UBS Group AGDOUBLED27,299$10.2K
UBS Group AGNEAR_EXIT1,463$892.00

Quarterly 13F filings are due 45 days after each quarter ends.

The Street

last action Feb 2025
Recent actions
DateFirmActionRating
Feb 24, 2025Maxim Group
INITIATE
INITIATEBuy

Insider ledger

Form 4
$0
open-market buys or sells · 12 mo
DateInsiderTypeValue
May 31, 2026
CHEN MILTON
Co-Chief Executive Officer
OTHER2,870,069 sh
Mar 23, 2026
Leonard Jerry
Chief Financial Officer
AWARD$25.0K
Mar 23, 2026
Aisiku Imoigele
Co-Chief Executive Officer
AWARD$48.0K
Mar 23, 2026
Leonard Jerry
Chief Financial Officer
AWARD$25.0K
Mar 23, 2026
Leonard Jerry
Chief Financial Officer
AWARD$24.7K
Mar 23, 2026
Aisiku Imoigele
Co-Chief Executive Officer
AWARD$48.0K
Mar 23, 2026
Aisiku Imoigele
Co-Chief Executive Officer
AWARD$48.0K
Mar 23, 2026
Leonard Jerry
Chief Financial Officer
AWARD$25.0K

Earnings setup

Estimates
Nov 12
reports in 17 days
PeriodEPS est.Range30D rev.Revenue
Current Q———$0.00
Next Q———$0.00
Current FY———$0.00
Next FY———$0.00

Short side

FINRA· Sep 15, 2026
787,729
shares short
-47.1%
vs prior settlement
1.0
days to cover
≈1.4%
of shares outstanding
Recent activity
The latest filings, insider trades, analyst actions, press and options flow — newest first.
Oct 1, 2026 SEC
VSee Health filed an S-1 registration statement to register up to 3,540,000 shares of common stock for resale by…
S-1 — Impact 6/10
Sep 28, 2026 Earnings calendar
VSEE Q2 2026 Earnings Scheduled — 2026-09-28
Jun 30, 2026 Inst.
VANGUARD FIDUCIARY TRUST CO — DOUBLED
354,298 shares ($41.1K)
Jun 30, 2026 Inst.
GEODE CAPITAL MANAGEMENT, LLC — TRIM
207,081 shares ($23.9K)
Jun 26, 2026 SEC
VSEE Health received a default notice from ADI Funding, LLC on its $271,739 secured promissory note, alleging failures…
8-K — Impact 6/10
Jun 11, 2026 SEC
VSee Health entered into a Standby Equity Purchase Agreement (SEPA) with YA II PN, Ltd. for up to $10M in common stock…
8-K — Impact 7/10
May 31, 2026 Insider
CHEN MILTON disposed of 2,870,069 shares
Co-Chief Executive Officer
Mar 23, 2026 Insider
Leonard Jerry was granted 20,833 shares
Chief Financial Officer @ $1.20 ($25.0K)
Catalysts
Scheduled dates and disclosed events: earnings, FDA and trial readouts, halts, press releases. Colored dot = impact.
Upcoming
Nov 12, 2026
Earnings date
VSEE Q3 2026 Earnings Scheduled — 2026-11-12
Recent
Sep 28, 2026
Earnings date
VSEE Q2 2026 Earnings Scheduled — 2026-09-28
Aug 6, 2026
Listing
Delisted: VSEE — removed from the Nasdaq symbol directory
VSee Health, Inc. - Common Stock
Aug 5, 2026
Listing
Listing Status: VSEE — Normal (was Deficient)
VSee Health, Inc. - Common Stock | Nasdaq Financial Status Indicator D → N
Jul 31, 2026
Short interest
Short Interest: VSEE up 344% to 7.3M shares
Settlement 2026-07-31 | Days to cover: 1.00 | ≈13.14% of shares outstanding (est.)
Jul 15, 2026
Short interest
Short Interest: VSEE up 24% to 1.6M shares
Settlement 2026-07-15 | Days to cover: 1.00 | ≈2.96% of shares outstanding (est.)

SecBot reports

3 filings · 0 bullish · 3 bearish
All VSEE filing & press-release reports (3)